Press Release

30th August 2021
EnZen Therapeutics Thirona Bio investment
SAN DIEGO, California, 30th August, 2021 – EnZen Therapeutics, Inc. (“EnZen”) and Thirona Bio, Inc. (“Thirona”) today announced that EnZen has invested in Thirona under a convertible promissory note arrangement.
Enzen_Logo_white

EnZen Therapeutics Inc.,
6330 Nancy Ridge Dr # 104, San Diego,
CA 92121, United States
info@enzentx.com

Copyright © 2022 EnZen Therapeutics Inc. All Rights Reserved. Designed by best website design & maintenance company Mumbai WP Digitals